Skip to main content
Clinical Trials/CTRI/2023/02/049444
CTRI/2023/02/049444Completed未知

Clinical study to evaluate the efficacy of the Facial Serum in providing moisture retaining properties to the skin in a full face study design.

HNL Business Services India Private Limited0 sites35 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. A total 35 male and female subjects (25:75% i.e., 9 males :26 females
  • respectively) in general good health as determined from a recent medical
  • history, general physical examination, dermatological assessment.
  • 2. Subjects in the age group of 35-50 years (both ages inclusive).
  • Subjects belonging to one of the skin types dry, normal, oily or combination
  • 3. Subjects presenting dull and dry skin (normal to dry), along with early signs of aging (Signs of aging with mild to moderate (includes wrinkles-crow’s feet, nasolabial and frown lines) using 0-9 MSCR scale
  • 4. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist.
  • 5. Subject who agrees not to use any other product/treatment/home remedy/
  • except the provided product on their face during the study period other than the test product.
  • 6. Subjects who agree not to carry out bleaching or any other procedures
  • including facial etc. on face during the study period.
  • 7. Subjects who agree not to expose to excessive sun light. (Sun exposure not more than half an hour daily and during that time use of umbrella to cover face).
  • 8. Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow-up.
  • 9. Subjects willing to abide by and comply with the study protocol.

Exclusion Criteria

  • 1. Subject with any other signs of significant local irritation or skin disease.
  • 2. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
  • 3. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
  • 4. Subjects who do not agree to remove all jewellery on/around face (e.g., necklace, earrings, if possible nose ring), during VISIA CR imaging.
  • 5. Subjects having hair style which covers almost the entire forehead
  • 6. Subjects undergoing any treatment of any skin condition on their face
  • 7. Subjects not willing to discontinue other topical facial products.
  • 8. Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewellery or anything else.
  • 9. Pregnant women (as confirmed by UPT) and lactating women
  • 10. Subjects on any medical treatment either systemic/topical in the past 1 month or currently taking medication including food supplements.
  • 11. Subjects with skin allergy, history of atopic dermatitis or psoriasis
  • 12. Subjects who have participated in any other clinical trial in the last 3 months.
  • 13. Subjects using oral contraceptive pills or hormonal implants as birth control measures during the study
  • 14. Subjects who have undergone treatment with Botox/filler /bio stimulatory
  • molecules injection

Investigators

Similar Trials

A study to check the hydration benefits | Clinical Trial